Paid and presented by Resmed. Day-to-day life for pro surfer Dani means being active and nomadic, so using his CPAP machine to treat and monitor his sleep apnoea means he gets a restful night ...

As sleep disorder diagnoses increase globally, effective treatment solutions are becoming more important. With over 30 years of experience, ResMed has become a global leader in sleep health and ...

ResMed Inc. (NYSE:RMD), a leader in the sleep and respiratory care market, finds itself at a critical juncture as it navigates a rapidly evolving landscape. The company, known for its continuous ...

Following another quarter of robust core performance and the release of its five-year strategic and financial outlook, William Blair sees ResMed well-positioned to capitalize on enduring sleep ...

Adjusted net income increased by 35% to $325 million. William Blair sees ResMed well-positioned to capitalize on enduring sleep health trends. The company reported sales of $1.224 billion ...

Lastly, Farrell believes the rise of GLPs will have a Botox effect on sleep apnea, as patients become more aware of the disease and doctors use all tools to treat the disease, including ResMed’s ...

Here's your health wrap. Resmed’s deals with sleep apnoea (snoring) and obesity is a key cause of the voluble disorder. So thinner people mean less snoring and less demand for Resmed’s CPAP ...

ResMed has since caught the eye of the Selector High Conviction Equity Fund, which views the sleep technology leader as "well positioned" for growth in FY25. Here's why Selector sees ResMed shares ...

Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

Sleep devices giant ResMed has brushed off investor fears that transformative weight-loss drugs threaten long-term demand for its sleep apnoea devices after posting better-than-expected first ...